Bumpy start to Forward Pharma’s IPO
![Foto: PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article4712639.ece/ALTERNATES/schema-16_9/Florian%2520Sch%25C3%25B6nharting.jpg)
The stage had been set for a good development on the first day of trading on the Nasdaq Global Select Market for the Danish biotech company Forward Pharma last Wednesday, but things did not quite pan out.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Forward Pharma’s IP rights impress
For abonnenter
Danish company to wage war on drug giant
For abonnenter
Biotech boss joins Forward Pharma’s board
For abonnenter